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Background: The prevention of type 2 diabetes is recognised as a health care priority. Lifestyle change has proven
effective at reducing the risk of type 2 diabetes, but limitations in the current evidence have been identified in: the
promotion of physical activity; availability of interventions that are suitable for commissioning and implementation;
availability of evidence-based interventions using new technologies; and physical activity promotion among ethnic
minorities. We aim to investigate whether a structured education programme with differing levels of ongoing
support, including text-messaging, can increase physical activity over a 4 year period in a multi-ethnic population
at high risk of diabetes.
Methods/Design: A multi-centre randomised controlled trial, with follow-up at 12 and 48 months. The primary
outcome is change in ambulatory activity at 48 months. Secondary outcomes include changes to markers of
metabolic, cardiovascular, anthropometric and psychological health along with cost-effectiveness. Participants
aged 40–74 years for White European, or 25–74 years for South Asians, with an HbA1c value of between 6.0 and < 6.4 %
(42 and 47 mmol/mol) or with a previously recorded plasma glucose level or HbA1c value within the high risk
(prediabetes) range within the last five years, are invited to take part in the trial. Participants are identified
through primary care, using an automated diabetes risk score within their practice database, or from a database
of previous research participants.
Participants are randomly assigned to either: 1) the control group who receive a detailed advice leaflet; 2) the
Walking Away group, who receive the same leaflet and attend a 3 hour structured education programme with
annual maintenance sessions delivered in groups; or 3) the Walking Away Plus group, who receive the leaflet,
attend the structured education programme with annual maintenance sessions, plus receive follow-on support
through highly-tailored text-messaging and telephone calls to help to aid pedometer use and behaviour change.
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Discussion: This study will provide new evidence for the long-term effectiveness of a structured education
programme focused on physical activity, conducted within routine care in a multi-ethnic population in the UK. It will
also investigate the impact of different levels of ongoing support and the cost-effectiveness of each intervention.
Trial registration: ISRCTN83465245 Trial registration date: 14/06/2012
Keywords: Prevention, Impaired glucose regulation, Type 2 diabetes, Prediabetes, Walking, Physical activity, Pedometer,
Structured education, Primary care, Randomised controlled trial, mHealthBackground
According to the World Health Organisation (WHO),
type 2 diabetes mellitus (T2DM) is the third leading
cause of mortality globally and represents one of the
greatest health challenges for modern society, both in
the UK and worldwide [1]. The International Diabetes
Federation estimate there are 387 million people living
with diabetes, and this is predicted to rise to 592 million
by 2035 [2]. The healthcare expenditures associated with
T2DM, the commonest form of diabetes, are substantial
and having T2DM drastically increases lifetime healthcare
expenditures [3].Diabetes currently accounts for approxi-
mately 10 % of the total health resource expenditure in
the UK and is projected to account for around 17 % in
2035⁄2036, due to a sharply increasing prevalence [4].
Consequently health care organisations have recognised
the need for policy and recommendations aimed at pre-
vention at the international, national and regional level.
In England this has taken the form of the National
Health Service (NHS) Health Checks Programme [5],
designed to screen and treat those at risk of vascular
disease in adults between 40 and 75 years. The National
Institute of Health and Care Excellence (NICE) have
also recently issued guidance aimed at the prevention
of T2DM in at-risk adults [6].
The status of being at high risk of T2DM refers to an
intermediary glucose control category that is outside the
normal range but below that needed to diagnose T2DM.
This intermediary range has historically been termed
‘prediabetes’ or ‘intermediate hyperglycemia’ and classi-
fied through oral glucose tolerance test defined impaired
fasting glucose or impaired glucose tolerance [7] . Along
with traditional definitions, an International Expert
Committee convened by the International Diabetes
Federation and NICE now also recognise that HbA1c
can be used to identify those at high risk of T2DM in
the range of 6.0 % - 6.4 % [6, 8]. Twenty five to 40 % of
individuals in these risk categories go on to develop
T2DM over a 10 year period and as many as 70 % will
eventually develop T2DM over the course of their lifetime
[9]. While we recognise there is controversy and lack of
consensus in terminology for these categories of glucose
dysregulation, we refer to prediabetes henceforth to aid
readability.Lifestyle interventions aimed at weight regulation,
dietary modification and increased physical activity
have successfully reduced the risk of T2DM in those
with prediabetes in diverse settings [10] and are recom-
mended as the first level of intervention for the prevention
of T2DM [6, 11]. However, several limitations in the evi-
dence have not been adequately addressed. These include
effective interventions to promote physical activity, avail-
ability of interventions that are suitable for commissioning
and implementation, use of new technologies to increase
the scalability of interventions, and the promotion of
health behaviour within ethnic minorities. Each of these
limitations is discussed below followed by an introduc-
tion to how structured education and new technologies
may be employed as a solution in the context of the
NHS in the UK.
Physical activity
Although physical inactivity is one of the most important
lifestyle determinants contributing to the risk of both
T2DM and cardiovascular disease [12–14], there is little
direct evidence that previous T2DM prevention pro-
grammes have resulted in clinically significant increases in
physical activity [15], even when this health behaviour is
the primary intervention target [16]. The effectiveness of
diabetes prevention programmes could therefore be en-
hanced if effective, evidence-based strategies for increasing
physical activity are developed and evaluated within the
context of diabetes prevention in primary care.
Translation into routine care
Trials of the efficacy of lifestyle interventions in the pre-
vention of T2DM have evaluated highly resource intensive
programmes, beyond the level that could be rolled out in
the real world given resource limitations and competing
clinical needs [17]. Whilst there is mounting evidence
internationally that the approach used in efficacy trials can
be translated into approaches suitable for implementation
in a community or primary care setting [18, 19], there is
limited evidence for the long-term effectiveness of these
programmes, and evidence-based behaviour change tech-
niques to support the maintenance of behaviour change.
In addition, there has been a lack of systematic approaches
to translating evidence into practice within the UK setting.
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the resources and infrastructure within primary care
and compliant with NICE guidelines are being developed
[20], but there is a need to ensure these are thoroughly
evaluated over the longer-term.
Use of new technologies to increase scalability
New technologies such as the internet (eHealth) and mo-
bile phones (mHealth) offer great potential for the delivery
of behaviour change interventions, given their scalability,
reach, and capacity to offer highly-tailored, interactive be-
haviour change support. Text messaging interventions
have shown promise in supporting medication adherence,
physical activity, weight loss, smoking cessation and pre-
vention/management of chronic disease, either as a stan-
dalone intervention or in combination with other modes
of delivery, e.g. face to face [9, 21–25]. However, these in-
terventions are rarely based on evidence and offer general
rather than highly tailored support. There is uncertainty
about the long-term effectiveness of theory driven and
evidence-based behaviour change interventions using
mHealth technology that can be integrated into routine
diabetes prevention pathways within primary care [26].
Ethnicity
In industrialised societies, some minority ethnic groups
are known to have a substantially elevated risk of T2DM.
South Asians (SAs), the largest ethnic minority in the UK,
have prevalence and progression rates for diabetes that are
up to four times greater than the general population [27].
This elevated risk of chronic disease is compounded by
lifestyle factors, of which the most notable is physical
inactivity. SAs residing in the UK have been shown to
be substantially less active with lower levels of cardiovas-
cular fitness than the general population [28–30]. This dif-
ferential in physical activity behaviour and levels of
cardiorespiratory fitness has been linked to the increased
prevalence of chronic disease and higher rates of insulin
resistance seen in SA populations [30, 31]. Therefore SAs
represent a priority group in the prevention of T2DM.
However, there is limited evidence that diabetes preven-
tion programmes within a European context have been ef-
fective at targeting lifestyle behaviours and improving
health in minority ethnic groups.
Structured education for the prevention of T2DM
There is encouraging pilot evidence that the limitations
highlighted may be addressed by combining structured
education with pedometer use [32]. Structured education
refers to educational interventions, generally delivered to
small groups, aimed at the promotion of self-management
and health behaviour and underpinned by established
health behaviour theories, a written curriculum and
standardised educator training and quality assurancepathways. Structured education has been widely used
as a central part of diabetes management pathways
within routine care and has been recommended by
NICE since 2003 [33]. The Diabetes Education and
Self-Management for Ongoing and Newly Diagnosed
(DESMOND) programme is one of the most prominent
structured education programmes for people diagnosed
with T2DM available nationally to commissioning orga-
nisations in the UK and the only programme to
undergo a multi-centred randomised controlled trial to
quantify effectiveness and cost-effectiveness [34, 35].
The DESMOND trial reported reductions in cardiovas-
cular disease risk profile, reduced depression, enhanced
smoking cessation, and weight loss whilst being highly
cost-effective at £2092 per QALY gained [34, 35]. Given
the existing wide spread infrastructure of the DESMOND
model, it has started to be adapted to the prevention arena
as a feasible and scalable model for implementing diabetes
prevention programmes within primary care and public
health [20].
Pilot work concluding with a single-centre randomised
controlled trial demonstrated that the approach used to
promote self-management in the DESMOND programme
can be tailored to those identified with prediabetes in
the promotion of physical activity. The Prediabetes
Risk Education and Physical Activity Recommendation
and Encouragement (PREPARE) structured education
programme was found to increase physical activity levels
and substantially reduce fasting and post-challenge glucose
levels in a multi-ethnic population over 12 months when
combined with personalised pedometer use [32]. Given the
relevance to healthcare providers and commissioners, it is
important to investigate the effectiveness of this approach
further when translated into routine clinical care.
Whilst structured education has been identified as a po-
tentially effective method of promoting behaviour change
in the prevention of T2DM, guidelines recommend the
provision of regular ongoing support [6, 36]. It is essential
to develop sustainable and scalable approaches, such as
mHealth, to enhance and reinforce the aims of structured
education programmes or other face-to-face behaviour
change interventions.
Given the above considerations, there is an identified
need to develop and evaluate the use of structured edu-
cation as a tool for promoting health behaviour change
in those with prediabetes with tailored, ongoing support
through low-resource approaches. Here we test whether
the approach used in the PREPARE structured education
programme, which has proven efficacy [32, 37], can pro-
mote long-term changes to physical activity and whether
the programme’s effectiveness is enhanced through the
use of a follow-on support programme combining ped-
ometer self-monitoring with tailored text-messaging and
telephone calls.
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1. To investigate whether an intervention to support
physical activity change and maintenance, offered to
an ethnically diverse population with prediabetes,
can lead to sustained increases in physical activity
over four years.
2. To investigate the effectiveness of the intervention
when delivered at two levels of intensity, with
and without follow-on support that enhances
self-monitoring with pedometers through tailored
text-messaging and telephone calls.
3. To investigate the effect of the intervention within
White Europeans and South Asians sub-groups.
4. To conduct a within-trial and long-term economic
evaluation of both intervention conditions using the
costs and benefits arising from the study, rates of
progression to T2DM, biomedical outcomes, NHS
resource use, and quality-of-life.
Methods/Design
Study design
The study comprises two phases: a development and pilot-
ing phase of the text-messaging support for pedometer use
and a multi-centre randomised controlled trial. The devel-
opment phase has been submitted for publication else-
where, while the present article describes the trial phase.
The trial is a multi-centre randomised controlled trial
comparing two modes of physical activity intervention
with a control condition. The study is designed to ad-
here to internationally recognised criteria for developing
complex interventions [38]. The design of the study and
flow of participants is described in Fig. 1. The study is
being run across two centres, Leicester and Cambridge,
UK. A total of 1308 participants will be recruited, with
66 % (n = 863) recruited from Leicester. The aim is to
have at least 25 % (n = 327) of the total cohort from a
South Asian ethnic origin to allow for increased general-
isability and the ability to stratify results by ethnicity
(see Sample Size).
The trial is sponsored by the University of Leicester
and ethical approval was granted by the NHS National
Research Ethics Service, East Midlands Committee,
which co-ordinates ethical permissions across the fol-
lowing study and recruitment sites:
 University Hospitals of Leicester NHS Trust
 Leicester City Clinical Commissioning Groups
(CCG)
 West Leicestershire CCG
 East Leicestershire and Rutland CCG
 University of Cambridge
 MRC Epidemiology Unit
 Cambridge and Peterborough CCG Cambridge University Hospitals NHS Foundation
Trust
Recruitment of participants
The primary method of recruitment is through the NHS
Health Checks programme. The NHS Health Check is
a screening programme run in the UK, designed to
identify and treat vascular disease risk (heart disease,
stroke, diabetes, and kidney disease) in all individuals
aged 40–74 years [5]. As part of this, many primary
care practices now have HbA1c or fasting glucose
values recorded for their patients. The research teams
in both Leicester and Cambridge are working in collabor-
ation with practices that are providing the Health Checks
programme to recruit those found with prediabetes, and
who are not currently receiving a systematic diabetes
prevention pathway. To help with this process, re-
cruited practices are trained to run an established auto-
mated diabetes risk score within their practice database
[39]. A function within the risk score uses a Morbidity
Query Information Export Syntax (MIQUEST) search
to identify all individuals who have had a previous
blood glucose or HbA1c result recorded in the predia-
betes range (see Table 1) over the previous five years
[39]. In Cambridge, participants meeting the inclusion
criteria are also being recruited from existing popula-
tion level research databases.
Participant invitation
Eligible individuals identified as having an HbA1c or
blood glucose value within the prediabetes category (see
Table 1) within the last 5 years are sent an invitation let-
ter, a brochure about the study, and a reply slip. For
those recruited directly from primary care, the invitation
letters are sent by the primary care practice where the
search was conducted. For those recruited from existing
databases, the invitation is sent from the Principal Inves-
tigator of that study. Individuals who are interested in
taking part are asked to return a reply slip directly to the
PROPELS research team. Interested participants are sent
the full study patient information sheet along with a
confirmation letter and an appointment is arranged for a
baseline visit.
Eligibility criteria
Patients are eligible for the trial if they are:
 Aged 40–74 years old for white European, or aged
25–74 years old for South Asian
 Have a previously recorded plasma glucose or
HbA1c value in the prediabetes range within the last
five years (see Table 1)
 Have access to a mobile phone, and willing to use it
as part of the study
Baseline visit
Randomisation
T2DM diagnosed.
Referred to routine care
12 month follow-up
48 months follow-up
12 month follow-up
Information leaflet WA programme
Telephone and text 
message support
12 month follow-up
WA maintenance 
session (12 months)
WA maintenance 
session (24 months)
WA maintenance 
session (36 months)
48 months follow-up 48 months follow-up
WA maintenance 
session (12 months)
WA maintenance 
session (24 months)
WA maintenance 
session (36 months)
Telephone and text 
message support
Telephone and text 
message support
Telephone and text 
message support
WA Walking Away 
WA programme
Fig. 1 Flow of participants through the study
Table 1 Categories of glycaemic control used for this trial
Normal Glycaemia Prediabetes** Type 2 Diabetes
Upper value Lower value Upper value Lower value
HbA1c (%)* <6.0 ≥6.0 <6.5 ≥6.5
HbA1c (mmol/mol)* <42 ≥42 <48 ≥48
Fasting plasma glucose (mmol/l)* <5.5* ≥5.5 <7.0 ≥7.0
2-hour post challenge glucose (mmol/l) <7.8 ≥7.8 <11.1 ≥11.1
*NICE guidelines (2012) [6]
**Levels within this range within the last 5 years required for participation in the PROPELS study
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 Unable to take part in ambulatory-based activity
 Pregnant
 Involved in other related intervention studies
 Diagnosed with diabetes, or diabetes detected at
baseline visit
 Unable to understand basic written and verbal
English
 Unable to give informed consent
Algorithm of exclusion for participants found to have
T2DM at baseline
At Leicester anyone who has an HbA1c in the diabetes
range (see Table 1) at baseline is recalled for a second
confirmatory test, and if diabetes is confirmed they are
referred back to their physician for routine care. At
Cambridge the participant’s primary care physician is in-
formed of the need to confirm diagnosis as appropriate.
Individuals found to meet the WHO (2011) [40] criteria
for diagnosis of diabetes are excluded from the study.
Algorithm for inclusion for participants found to have
normal glycaemia at baseline
All individuals found to have normal glycaemia at base-
line are included in the study provided they meet the in-
clusion criteria requiring a historical blood glucose level
within the prediabetes range within the previous 5 years.
Randomisation
Once baseline data have been collected, participants are
randomised (stratified by sex and ethnicity) using an on-
line randomisation tool hosted at the University of
Leicester Clinical Trials Unit. Individuals are randomised
(1:1:1) to the control group, the Walking Away Group
or the Walking Away Plus Group. The exception to this
is individuals recruited from the same household, who
are randomised to the same group. Participants are in-
formed of their allocated treatment after baseline mea-
sures are completed. Study allocation is concealed from
the study measurement teams conducting the 12-month
and 48-month follow-up.
Study interventions
Detailed advice leaflet (Control Group)
Participants in the control group receive an advice
leaflet detailing the likely causes, consequences, symp-
toms and timeline associated with prediabetes, as well
as information about how physical activity can reduce
the risk of developing T2DM. This leaflet is informed
by Leventhal’s Common Sense Model [41], which also
underpins the structured education programme. Par-
ticipants also continue to receive standard care from
their GP.Structured education programme followed by annual
group maintenance sessions (Walking Away Group)
Participants are given the same advice leaflet as the con-
trol group and invited to attend an updated version of
the PREPARE structured education programme within
three months of their baseline clinic visit, titled Walking
Away from Type 2 Diabetes. Participants are also offered
annual maintenance education sessions, revisiting the
key messages of the initial Walking Away programme,
and discussing any benefits and barriers they have expe-
rienced to increasing their physical activity.
The Walking Away programme fully incorporates the
curriculum and content of the successful PREPARE
programme [32, 37], but was renamed and updated to
incorporate current terminology and guidance [6] and
now includes an accredited educator training and quality
assurance pathway. The PREPARE programme has pre-
viously been shown in a single centre RCT to increase
ambulatory activity by 2000 steps per day compared to
control conditions over a 12-month period when com-
bined with pedometer use with sustained improvements
in glucose levels. [32, 37]
The programme is delivered by two trained educators to
groups of up 10 participants (who are welcome to bring a
guest). The content of the programme, examples of activ-
ities and the underlying theoretical structures are pre-
sented in Table 2. The key aim of the programme is to
increase participants’ physical activity predominantly
through increased walking, and to prompt the use of self-
monitoring and feedback using pedometers. During the
programme participants use their daily habitual step count
(measured at baseline prior to the education programme)
to set personalised activity goals. They are provided with a
pedometer (Yamax SW200) as a self-monitoring tool.
Typically, sedentary participants are encouraged to in-
crease their activity levels by at least 3000 steps per day,
equivalent to around 30 minutes of walking. Those achiev-
ing more than 6000 steps per day are encouraged to try to
reach at least 9000 steps per day, an amount that is likely
to include 30 minutes of walking activity in addition to
usual daily activity [32]. Those achieving more than 9000
steps per day are encouraged to at least maintain their
current activity levels and develop further goals should
they wish to. Goal attainment is encouraged through the
use of proximal objectives, such as increasing ambulatory
activity by 500 steps per day every two weeks. Participants
are encouraged to make an action plan detailing where,
when and how their first proximal goal will be reached, to
repeat action planning for each new proximal goal, to
wear their pedometer on a daily basis and to self-monitor
their ambulatory activity using a specifically designed
steps-per-day diary. A full description of the rationale, de-
velopment and efficacy of the work underpinning Walking
Away are detailed elsewhere [32, 42].
Table 2 Outline of the Walking Away programme (delivered to the Walking Away group and the Walking Away Plus group)
Module: Main aims: Example activity: Theoretical
underpinning:
Time
weighting
Patient Story Give participants a chance to share their
knowledge and perceptions of prediabetes
and highlight any concerns they may want
the programme to address.
Participants are asked to share their story, how
they were diagnosed with prediabetes and
their current knowledge of prediabetes
Common Sense
Model [67]
15 %
(30 minutes)
Professional
story and risk
communication
Use simple non-technical language, analogies,
visual aids and open questions to provide
participants with an overview of healthy glucose
metabolism, the aetiology of prediabetes and
diabetes, and the risk factors and complications
associated with elevated blood glucose levels
(cholesterol, blood pressure, cardiovascular
risk etc.). Support participants to consider how
their individual risk factors (modifiable and
non-modifiable) can stack up, identify their
own personal risk factors, and identify options
to reduce their risk
1) The following model for insulin resistance is
used: Glucose moves from the blood into cells
to be used as energy via a door with a lock on
it. Insulin keys are used to open the lock; insulin
resistance occurs when the cell locks get rusty.
Common Sense
Model [41], Social
Cognitive Theory
[68], Dual Process
Theory [69]
35 %
(60 minutes)
2) Using resources participants are encouraged
to share their knowledge of their risk factors for
developing T2DM, plot their own personal risk
factors and work out which risk factors they can
personally alter.
Diet Give participants an accurate understanding of
the link between dietary macro-nutrients and
metabolic dysfunction
Participants are asked to group food models
into their dominant macro-nutrient groups
(i.e. carbohydrate, fat, protein). Fats and oils are
divided into saturated, polyunsaturated and
monounsaturated categories.
Social Cognitive
Theory [68] Dual
Process Theory
[69]
10 %
(20 minutes)
Physical activity Use simple non-technical language, analogies,
visual aids and open questions to help
participants: identify how physical activity
improves glucose control; understand the
current physical activity recommendations
and how these relate to steps per day; explore
options for incorporating physical activity
(primarily walking) into everyday life; identify
barriers to exercise; form action plans; encourage
participants to use their provided physical activity
diaries and pedometers; and set personal step
per day goals.
1) Participants are encouraged to share
their knowledge of the various exercise
recommendations and to work out how each
recommendation may affect their health.
Social Cognitive
Theory [68]
40 %
(70 minutes)
Implementation
Intentions [70]
Dual Process
Theory [69]
2) Participants are provided with a physical
activity diary and pedometer and helped to
set their first action plan.
Yates et al. Trials  (2015) 16:289 Page 7 of 16Following the initial group session, participants are
offered annual group-based maintenance sessions at 12,
24 and 36 months, each lasting 2.5 hours. These mainten-
ance sessions are designed to re-visit the key messages of
the first session, and build self- efficacy through the shar-
ing of successes, problem solving barriers, goal setting and
self-monitoring using pedometers. This mode of delivering
behaviour change maintenance is designed to be directly
relevant to primary care pathways where annual clinical
follow-up of those with a high risk of chronic disease, such
as prediabetes, is recommended [5, 6].
Structured education programme plus follow on support
(Walking Away Plus)
Participants receive the same advice leaflet, Walking Away
structured group education programme and annual main-
tenance sessions. In addition they are introduced and
given access to a highly tailored text-messaging follow-on
service designed to support behaviour change and pedom-
eter use with additional telephone calls from educators
that are initiated after attendance at the Walking Away
programme. Details of the text messaging and telephone
follow-on support service are detailed in Table 3 and havebeen submitted for publication elsewhere. In brief, ap-
proximately one week after the Walking Away session,
an educator telephones the participant to help them
identify a short- and long-term step goal and action
plan for the next six months, and to elicit information
on tailoring variables including confidence in increasing
physical activity, previous experience of physical activity
and potential mobility issues that prevent walking being
the primary activity. The educator records the information
in an online form and saves it on a database for use by the
text-messaging programme. A key feature of the text-
messaging and pedometer support is that participants are
prompted to text in their weekly step count. They then re-
ceive automated feedback by text message tailored to the
extent to which they achieved their goals, in relation to
the tailoring variables. Participants also receive text-
messages using evidence-based behaviour change tech-
niques and a six month telephone call to review their goals
and action plans, prompt problem solving and provide
social support. The key techniques used in the follow-on
support are goal setting (behaviour), action planning, self-
monitoring, goal review, problem-solving and social sup-
port [43]. The intensity of the ‘follow-on support’ varies
Table 3 ‘Follow on’ support for the Walking Away Plus Group, repeated over the four years of intervention
Time point from
education attendance
Type of contact and
frequency
Content (behaviour change techniques and their delivery)
0 months First group session (3 hrs) • As the ‘Walking Away’ group plus extra 15–20 minutes at end of the session to explain the
follow-on support and what to expect over the next 12 months in terms of text-messaging,
pedometer support and telephone calls.
• One week of self-monitoring (using the pedometer and activity diary) and text messages
prompting participant to ‘text in’ their weekly step total at the end of the week (‘baseline’ steps).
1 week First telephone call from
educator (15 minutes)
• Educator prompts participant to set an action plan and personal short term and long term
goals informed by the baseline steps, and asks participant about their confidence to
achieve goals and previous levels of physical activity. Educator records this information on
an online form which saves to a database for use in tailoring subsequent text-messages.
0-2 months Text message contact
(1–3 per week)
• Participant monitors activity (pedometer step counts) each week, using a pedometer, an
activity diary and a converter to translate activities other than walking into steps.
• Participant receives text-messages asking them to ‘text in’ weekly step count total.
• Participant receives feedback by text-message tailored to goal achievement, confidence,
and previous physical activity levels.
• Participants who do not make progress with goals receive ‘problem solving’ texts, asking
them to text in barriers, followed by tailored replies.
2-6 months Text message contact
(one per week)
• Weekly tailored messages targeting attitudes and beliefs, motivation, self-efficacy and
self-regulation of PA behaviours.
• Participant is asked to self-monitor and record steps for 1 week and text in weekly amount
(ahead of 6 month telephone call)
6 months Telephone contact;
15 minutes
• Educator gives feedback on goal progress, and reviews goals.
• Educator prompts problem solving in relation to barriers.
• Educator identifies and highlights benefits experienced.
• Educator discusses whether experiences of behaviour change are satisfying and reinforcing.
• Educator provides social support.
• Educator prompts continued goal setting and action planning.
7-12 months Text message contact once
per month
• Monthly tailored messages target attitudes and beliefs, motivation, self-efficacy and
self-regulation of physical activity behaviours.
• Participant is asked to self-monitor and record steps for 1 week and text in weekly amount
(ahead of 12 month group education session)
OPTIONAL Telephone contact;
15 minutes
• Educators call participants who do not respond to text requests for step counts, to
encourage participation and solve any problems.
12 months Walking Away maintenance
session; 2.5 hours
• See Walking Away group (Table 2).
This annual structure is repeated each year following each group education maintenance session for the 4 year intervention period
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over the four years of the study. Participants who do not
wish to receive text-messages can opt out at any time.
Educator recruitment, training and quality assurance
(intervention fidelity)
Educators can be registered health care professionals
(e.g. nurse, dietician) or a suitable non-registered profes-
sional (e.g. Health Trainer). Across the study sites, 16
educators have been recruited from a range of registered
and non-registered Health Care Professionals from local
healthcare providers and other appropriate settings. This
mix of personnel was included in order to make the
study as pragmatic and generalisable as possible to rou-
tine health care systems. To ensure that all interventions
are delivered by educators as planned, a fidelity standardoperating procedure has been put in place. All educators
attended an initial two day training course to ensure that
they understood the theories and philosophy that under-
pin the Walking Away programme and the content and
resources used within it. All educators were given a
written curriculum to support their delivery of the
programme and given the opportunity to practise delivery
of the programme. Quality assurance of delivery is
undertaken to assess educational style and content
using established tools used within routine care
through the DESMOND Collaborative [44]. Educators
receive structured and instructive feedback from their
assessor and key goals and action plans are developed
in order to help them improve their performance. Prior
to the delivery of the one year intervention, educators
received training to be able to deliver the Walking
Table 4 Participant assessments at each time point
Clinical Assessment 0 months 12 month 48 months
Family history of disease X X X
Medication status X X X
Smoking status X X X
Muscular/skeletal injury X X X
Blood pressure* X X X
Height* X X
Weight* X X X
Waist circumference* X X X
Arm and leg length X
Body fat percentage X X X
Fasting and 2-hr glucose and insulin
(Leicester only)
X X X
HbA1c* X X X
Lipids* X X X
Urea & Electrolytes* X X X
Liver Function Tests* X X X
7 Day Step Count & Physical Activity
(accelerometer)
X X X
Recent Physical Activity
Questionnaire (RPAQ)
X X X
Dietary questions X X X
Brief Illness Perceptions
Questionnaire (BIPQ)
X X
Physical activity self-efficacy X X X
Enactment of techniques
(Groups 2 & 3 only)
X X
EQ-5D; SF-8 X X X
Hospital Anxiety and Depression
Scale (HADS)
X X X
Sleep X X X
Neighbourhood Environment
Walkability Survey (NEWS)
X
Use of health resources X X X
*Results of these assessments are sent to the participant and their primary
care physician
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a written curriculum.
Educators attended additional training in delivering the
telephone calls to participants in the ‘Walking Away Plus’
group. The training was supported by an extensive cur-
riculum outlining the contents (behaviour change tech-
niques, patient-centred communication skills) and mode
of delivery of the follow-on support. The curriculum also
contains standardised scripts that educators are asked to
follow, an explanation of the intervention fidelity proce-
dures, and standardised reflection sheets and checklists to
promote and assess fidelity of the phone calls. Educators
are asked to audio-record the telephone calls, listen back
to a sample, complete the checklists, and discuss these
with the intervention lead. The number of calls assessed
and their frequency depends on the competence level of
the individual educators as well as the year of intervention
delivery. Monitoring the delivery of the text-messaging
system is done on a weekly basis by examining automatic-
ally generated lists of messages sent and received.
Study outcomes
Data collection clinics are run by research nurses in the
Leicester Diabetes Centre, the MRC Epidemiology Unit,
Cambridge and other local community centres and clinic
areas. All staff have been trained in study procedures
and data are collected following standardised operating
procedures. Written informed consent is obtained from
all participants prior to the commencement of data col-
lection. Details of all clinical assessments and outcome
measures are provided in Table 4. Participants are sent a
letter with details of selected clinical results after each
visit, and their results are also sent to their general
practitioner.
Primary outcome
The primary outcome measure is change in ambulatory ac-
tivity (steps per day) at 48 months, assessed by accelerom-
eter (Actigraph GT3X+) with an intermediary assessment
at 12 months. Participants are asked to wear the acceler-
ometer on a waistband (in the right anterior axillary line)
for seven consecutive days during waking hours following
their baseline and follow-up visits. In addition, participants
are asked to fill in a log sheet each day that they wear the
accelerometer indicating time the accelerometer was taken
off at night, time they went to sleep, time they woke up
and time the accelerometer was attached. At the end the
seven days of wear, participants are asked to return the ac-
celerometer and the log sheet to the research team in a
pre-paid envelope. Raw acceleration data are captured and
stored at 100 Hz. Data processing will be undertaken on
commercially available analysis tools. At least three days
valid wear is required to count as a valid recording.
Non-wear time is determined by one hour or more ofconsecutive zero counts. Due to the potential for bias
between groups in factors used to acquire valid accelerom-
eter data, average wear time and the number of valid days
will be included as covariates in the analysis.
Secondary outcomes
Accelerometer
The accelerometer used to measure the primary out-
come, detailed above, is also used to assess the number
of censored steps taken per day, defined as steps taken
above an intensity used to distinguish between purpose-
ful and incidental ambulation [45]. In addition, com-
monly used cut-points will be used to distinguish
between time spent sedentary and in time spent in light-
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We will also use this data to assess compliance to the
physical activity recommendation of undertaking at least
150 minutes of moderate-to-vigorous intensity physical
activity per week in bouts of at least 10 minutes.
Time spent lying, standing, sitting and postural transitions
Participants are also asked to wear an activPAL3™ de-
vice for the same seven days as the ActiGraph acceler-
ometer. This is a small slim thigh worn monitor that
uses accelerometer-derived information about thigh
position to determine body posture (i.e., sitting/lying,
standing and stepping). The activPAL3™ is initialised
using manufacturer’s software with the default settings
(i.e., 20Hz, 10s minimum sitting-upright period) and
participants are asked to wear the device continuously
(24 hours/day). The device is covered with a nitrile sleeve
and fully wrapped in one piece of waterproof dressing
(Hypafix Transparent) to allow participants to wear the
device during bathing activities. The activPAL3™ is
worn on the midline anterior aspect of the upper thigh
and secured using hypoallergenic waterproof dressing
(Hypafix Transparent).
Recent Physical Activity Questionnaire (RPAQ)
Self-reported physical activity is measured using the
RPAQ. This assesses physical activity across four do-
mains (domestic, recreational, work, commuting) over
the previous month. The domestic section contains
questions regarding computer use, TV-viewing and stair
climbing at home. The questions in the recreational do-
main ask about frequently performed activities, includ-
ing frequency and duration. The work domain examines
the level of physical activity associated with their current
employment, and commuting assesses four modes of
usual transport: walking, cycling, car, and public transport.
It has shown moderate-to-high reliability for physical
activity energy expenditure, and good validity for ranking
individuals according to their time spent in vigorous in-
tensity physical activity and overall physical activity en-
ergy expenditure [47]. Participants also complete the
Neighbourhood Environment Walkability Survey (NEWS)
which captures the environmental context in which
participants live and will be used to assess environmental
determinants of physical activity and physical activity
behaviour change [48, 49].
Biochemical variables
Standard biomedical outcomes are assessed by venous sam-
pling. These consist of HbA1c, lipid profile (triglycerides,
HDL, LDL, total cholesterol), urea and electrolytes (sodium,
potassium, urea, creatinine) and liver function tests
(albumin, total bilirubin, alkaline phosphatase, alanine
transaminase).At the Leicester site only, participants are assessed for
fasting and 2-hour post challenge glucose and insulin
levels using an Oral Glucose Tolerance Test (OGTT).
The OGTT results will be used to provide greater clin-
ical insight into how the promotion of physical activity
affects metabolic health in prediabetes, given 2-hour glu-
cose and insulin levels better reflect peripheral insulin
sensitivity. Given that the new WHO guidelines [40]
have led to local clinical practice basing diagnosis of
T2DM on HbA1c criteria, the routine use of the OGTT
has been phased out of primary care. Therefore, in order
to comply with local guidelines and to avoid confusing
clinical management strategies in recruited practices,
OGTT samples taken in Leicester are frozen and will be
analysed after the final study visit (48 month) and not form
part of a diagnosis of diabetes. The OGTT involves a fast-
ing blood sample being taken from the patient before they
are then given a glucose load of 75 g. A second sample is
taken 2 hours later. Fasting and 2-hour plasma glucose and
insulin samples are taken at each clinical visit and stored in
a −80 °C freezer using standardised, stable methodology
within the Leicester Diabetes Research Centre.
Genetics
A blood sample for genetic analysis is also collected in
those who provide their consent. The aim of this sample
will be to investigate group level associations and interac-
tions of physical activity, obesity and genes in the develop-
ment of T2DM. The genetic assessments will be focused
on genes for which there are biological plausibility for
interaction.
Anthropometric and demographic variables
Body weight, body fat percentage, height and waist circum-
ference are measured to the nearest 0.1 kg, 0.5 %, 0.5 cm
and 0.1 cm respectively. Waist circumference is measured
using a soft tape mid-way between the lowest rib and iliac
crest. Arterial blood pressure is obtained from the right
arm of the seated participant. Three measurements are
taken and an average of the last two measurements will be
used. Total upper arm length, forearm length, total leg
length and lower leg length are measured on the left side
of the body. Information on ethnicity, medication history,
current smoking status, family history of diabetes in first
and second degree relatives, and muscular/skeletal injury
that prevents physical activity are obtained by self-report.
Cardiovascular risk
Cardiovascular risk is calculated using the Framingham
risk calculator.
Self-reported dietary behaviour
In order to capture dietary behaviour, two short question-
naires used in previous research studies by our group are
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questions are based on dietary questionnaires developed
for the EPIC (European Prospective Investigation of
Cancer and Nutrition) study and the international
NAVIGATOR (Nateglinide And Valsartan in Impaired
Glucose Tolerance Outcomes Research) study [50, 51].
Sleep
Participants self-report on two questions concerning sleep
duration over the past 24 hours and over a usual week.
There is accumulating evidence for an association between
short sleep duration (<6 hours per 24 hours) and long
sleep duration (≥10 hours per 24 hours) and metabolic
dysfunction [52].
Health related quality of life
Health related quality of life data is measured using the
European Quality of Life-5 Dimensions (EQ-5D) [53]
and the Short Form (SF-8) Health Survey [54]. The EQ-
5D is a standardized questionnaire that was developed
for use as a measure of health outcomes and defines
health in terms of five dimensions: mobility, self-care,
usual activities, pain or discomfort, and anxiety or depres-
sion. It is widely used to calculate ‘quality adjusted life
years’ (QALYs) which are essential to cost-effectiveness
analysis. The SF-8 is a self-administered questionnaire
measuring eight health domains (general health, physical
functioning, role physical, bodily pain, vitality, social
functioning, mental health and emotional roles) with
eight questions. The standard (4 week) recall format
will be used. Data from SF-8 is represented as a phys-
ical component score and a mental component score.
Depression and anxiety
Depression and anxiety are measured using the Hospital
Anxiety and Depression (HADS) Scale, to produce inde-
pendent subscales for anxiety and depression [55].
Health resources
A health resources questionnaire records the number of
times over the past 12 months that the participant has
seen a health care practitioner such as a GP, nurse or
other health workers, and the number of times they have
been to hospital. In addition, the contact and costs asso-
ciated with the intervention will be captured by the re-
search team. These costs will be inputted into the cost
effectiveness analysis of the intervention.
Process measures
Perceptions of diabetes risk
Perceptions and perceived knowledge of diabetes risk
is measured at 12 and 48 months using the validated
Brief Illness Perceptions Questionnaire (BIPQ) [56].
This eight item instrument uses an 11 point Likertscale (0 = no effect, 10 = complete effect) to measure
five cognitive diabetes risk representations (conse-
quences, timeline, personal control, treatment control,
and identity), two emotional representations (concern
and emotion) and risk comprehensibility (perceived
knowledge).
Self-efficacy in relation to physical activity
Self-efficacy is measured at baseline, 12 and 48 months.
Six items measure participants’ confidence in their abil-
ity to undertake any form of moderate- to vigorous-
intensity physical activity for 10 minute periods, increasing
incrementally from 10 minutes to one hour each day.
Items use a 100 % confidence rating scale (where 0 % = no
confidence, and 100 % represents complete confidence).
An overall score is calculated by summing the efficacy
scores for each time period and dividing by the number of
time periods.
Enactment of the behaviour change techniques
Participants’ use of behaviour change techniques in-
cluded in the Walking Away and Walking Away Plus
groups is assessed at 12 and 48 months. A 5-point Likert
scale (where 1 =most of the time and 5 = never) assesses
how often participants set goals, form action plans, use a
pedometer, complete an physical activity log, are aware
of their activity levels, and are trying to be more physic-
ally active.
Uptake and adherence to Walking Away and Walking Away
Plus interventions
Measures of uptake and adherence to the intervention
groups will include: 1) group session attendance to
Walking Away, 2) group session attendance to the an-
nual maintenance sessions at 12, 24 and 36 months 3)
proportion of phone calls completed, 4) number of par-
ticipants who registered for the text messaging service,
5) number of STOP messages received for test messa-
ging (i.e. number opting out of the text messaging and
pedometer support), 6) proportion of intended texts
sent, and 7) number of step count texts received from
participants relative to the number of requests they are
sent (engagement).
Qualitative process evaluation
A process evaluation will be conducted using a combin-
ation of ethnographic methods including observations of
education sessions and individual interviews. Briefly, we
will observe a sample of Walking Away sessions and
undertake interviews with a sample of participants from
all three trial groups. Analysis will be informed by the
constant comparative method; the focus will be explor-
ing whether and how participants engage with each
component of the intervention(s).
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Primary outcome
For 1-beta = 0.8, alpha = 0.025 (allowing for 2 a priori
comparisons against control conditions), SD = 4000
steps/day and a drop-out of 30 %, we require 436 per
group (1308 in total) to detect a 1000 steps/day differ-
ence in change in ambulatory activity (equivalent to 10
mins walking/day or 70 mins walking/week) between the
intervention groups and control group. Assuming 25 %
of participants in the total cohort are SA we have an
80 % power to detect around a 2000 steps/day difference
when comparing two intervention comparisons to the
control group (alpha = 0.025) in the SA population.
Several intervention studies with a follow-up of be-
tween 3 to 12-months reported a standard deviation of
change in ambulatory activity of around 3000 to 4000
steps per day in individuals with T2DM, prediabetes or
in sedentary individuals [32, 57–59].Therefore we have
anticipated a standard deviation of change of 4000 steps
per day. An intervention effect of 1000 steps was consid-
ered the minimum clinically significant difference be-
tween groups and equates to around a 4 % difference in
the risk of cardiovascular morbidity and mortality [13].
Secondary outcome
Given that around 95 % of the general population fail
to meet the Chief Medical Officer’s physical activity
guidelines when measured objectively by accelerome-
ters [60], this study also allows for the 10 % difference
in those meeting the current physical activity recommen-
dation to be detected at follow-up based on 1-beta = 0.8,
alpha = 0.025. Consistent with the calculation for ambula-
tory activity, this study has sufficient power (1-beta = 0.8,
alpha = 0.025) to measure a 10 minute/day difference in
change in the time spent in moderate-to-vigorous inten-
sity physical activity based on previous work undertaken
by our group [16].
This study has sufficient (1-beta = 0.8, alpha = 0.025)
power to allow for clinically meaningful differences for
change in the biochemical measures to be detected in
the entire study cohort and after stratification by ethni-
city; fasting glucose (0.3 mmol/l), 2-h glucose (1 mmol/l)
and HbA1c (0.25 %).
Furthermore assuming a conversion rate to T2DM in
the control group of at least 24 % over the course of
the entire study (4 years), we will have an 80 % power
to detect a 40 % reduction in the relative risk of T2DM
in both intervention groups compared to the control
group. The estimated conversion rate is at the lower
level reported for traditionally defined prediabetes [7, 61].
We anticipate that the inclusion of an HbA1c defined pre-
diabetes in this study will act to marginally lower the con-
version rates, whilst the inclusion of a large South Asian
group will act to increase the conversion rates.Data analysis
Analysis will involve two a priori comparisons; both
intervention groups will be compared to the control
group. Should any of these comparisons reveal a signifi-
cant difference, then a third a priori comparison will be
undertaken by comparing the difference between inter-
vention groups - this will be included as a secondary
analysis. Multiple linear regression analysis will be used
to investigate the differences in the change in physical
activity level achieved between groups at 48 months,
after adjusting for potential areas of bias between
groups, valid accelerometer wear time and the number
of valid wear days. Analysis will be conducted on the co-
hort as a whole and stratified by ethnic group; inter-
action terms will be used to quantify the effect of ethnic
group. We will also use interaction terms to assess
whether the effects of the interventions are modified of
gender, age, ethnicity, family history of T2DM or
whether prediabetes status was confirmed at baseline;
significant interactions will followed by stratified ana-
lysis. We will also assess change in physical activity at
12 months as a secondary outcome. The primary ana-
lysis will be based on analysing those with complete data
at each time point in the group to which they were rando-
mised. A sensitivity analysis will be undertaken to assess
the impact of imputing missing data through multiple im-
putation and through a per-protocol analysis by removing
those that failed to attend the initial Walking Away session
in both intervention groups; per-protocol analysis for the
Walking Away Plus group will be defined as removing
those that that failed to attend the initial Walking Away
session OR those that failed to register for or actively
stopped their text messaging support via the STOP func-
tion within the first 2 months.
Analysis of secondary biochemical and anthropometric
outcomes will be analysed using the same strategy and
at the same time-points as that described for the primary
outcome. Differentials in the time to T2DM between
groups will be plotted using the Kaplan–Meier method
for comparing survival curves; the log rank test will be
used to assess for differences between the groups.
Health economics
We will undertake a costing exercise to determine the
cost of delivering the initial interventions covering ex-
penditure such as educator time, educator training and
quality assurance. In addition we will determine the cost
of the follow-up maintenance support group-sessions
and the staff and other costs of the individually tailored
telephone and text messaging package for maintenance
support. Resource use incurred will be costed using ac-
tual costs in the trial and/or standard references for unit
costs such as Unit Costs of Health and Social Care [62].
In addition to the primary endpoint, we will analyse the
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on other outcomes that are pertinent to the long-term
economic analysis, i.e. use of antihypertensives and
lipid-lowering therapies, blood pressure, health utility
and incidence of T2DM.
Long-term costs and benefits of the interventions will
be evaluated through a combination of the within-trial
outcomes and decision-analytic modelling to simulate
long-term incidence ofT2DM, microvascular complica-
tions arising from T2DM and cardiovascular events.
Specifically for progression to T2DM, estimating long-
term progression will require a statistical model built
partly from incidence data from the trial. The underlying
incidence curve will be based on rates of progression in
the control arm, and a survival model with time-varying
hazards will be built to demonstrate the effect of a unit
change in physical activity on risk of T2DM over time.
This will allow the impact of alternative assumptions
about the degree of maintenance of physical activity be-
yond the 4-year follow-up period to be modelled. The
underlying progression of T2DM beyond the 4-year
follow-up will be estimated by the above 4-year survival
curve and assumptions about medium-term maintenance
of physical activity, but also informed by the trajectory
of survival curves from long-term diabetes prevention
studies such as the Finnish Diabetes Prevention study [63].
An important input for the modelling will be the effect
of increasing physical activity on cardiovascular risk.
The relationship between changes in physical activity
and cardiovascular risk will be incorporated into an
existing decision-analytic model of prevention of dia-
betes. This relationship will be informed by a recent
study that specifically calculated the effect of change in
ambulatory activity (steps per day) on cardiovascular dis-
ease risk [13]. The model will be chosen from existing
models used previously for work for NICE [64] on pre-
vention of diabetes or developed as part of the School
for Public Health diabetes prevention theme within
ScHARR, funded by the National Institute for Health
Research (NIHR). The economic model aggregates the
costs of the intervention, prescribed medications, therapy,
the costs of one-off treatments (e.g. cost of amputation),
and on-going treatment of complications (e.g. treatment
following stroke). The cardiovascular risks of participants
with prediabetes, or with diabetes will be estimated using
the UKPDS risk engines [65, 66]. A further adjustment
will be made so that the risk can be adapted for the
South Asian population using evidence advised by
clinical colleagues.
Separate evaluations will be undertaken for the overall
group and for the South Asian subgroup. Cost-
effectiveness will be reported in terms of incremental costs
and QALYS and the incremental cost-effectiveness ratio.
Uncertainty around the results will be explored throughprobabilistic sensitivity analysis and related techniques for
identifying the most important drivers of uncertainty,
which will be presented on a cost-effectiveness acceptabil-
ity curve and a cost-effectiveness plane.
Trial Steering Committee (TSC) and Data Monitoring and
Ethics Committee (DMEC)
The trial is overseen by TSC comprising an independent
chair, independent clinical and academic members and
the principal investigator. This committee is responsible
for the overall management and oversight of the trial.
The steering committee are blinded to all information
regarding treatment assignments until after the database
is locked for final analysis.
A fully independent DMEC reports to the TSC. This
comprises an independent chair and a statistician. The
DMEC are responsible for the interests of participant
safety and data integrity. The DMEC will undertake
safety data reviews every nine months, unless otherwise
deemed necessary. In addition the DMEC will also re-
view analysis plans.
Discussion
This trial will provide important insight regarding the long
term effectiveness and cost-effectiveness of a group-based
structured education programme for physical activity tar-
geting those with prediabetes within primary care, and the
effectiveness of a highly-tailored and evidence-based text-
messaging and telephone follow-on system designed to
support ongoing behaviour change and pedometer use.
NICE guidelines on diabetes prevention recommend the
use of group-based lifestyle intervention for prediabetes as
the cornerstone of any diabetes prevention pathway [6], so
it is important to investigate the use of structured educa-
tion within the prevention domain. It is imperative that
any intervention programme is carefully evaluated for
both clinical and cost-effectiveness, as well as its capacity
to be easily implemented into primary care. Whilst both
the effectiveness and cost-effectiveness of structured edu-
cation for those diagnosed with T2DM have already been
established [34, 35], and is recommended by NICE as best
clinical practice for the management of T2DM [33], there
is a lack of translational research within the context of dia-
betes prevention. Consequently this limits the capacity of
commissioners and policy makers to make informed
evidence-based decisions regarding the implementation of
national diabetes prevention programmes within primary
care. Furthermore there is a need to establish what the op-
timal levels of ongoing support are to ensure any behav-
iour change is maintained, taking into account the limited
resources available in most healthcare settings. This study
evaluates highly-tailored, evidence-based text-messaging
tool which requires few resources and time, and thus will
help address both of these limitations.
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tional programme and the follow-on text-messaging and
telephone support system have been specifically designed
to be translated into primary care. This type of lifestyle
intervention in prediabetes could be easily added to other
programmes currently on offer for the management of
type 2 diabetes, thereby allowing a range of structured
education packages and evidence-based mHealth inter-
ventions to be offered, to best serve the needs of the
diabetes pathways within primary care.
Trial status
Recruitment started in January 2014 and is still ongoing.
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